Colchicine for the treatment of COVID19, Cochrane Library

Review (4 RCTs; n=16,013) found colchicine probably has little to no influence on mortality or clinical progression in people hospitalised with moderate to severe COVID ‐19; there is uncertainty about the evidence of its effect in those with asymptomatic infection or mild disease.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news